PMC:7199903 / 13291-14194
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 348-359 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
T4 | 482-488 | https://glytoucan.org/Structures/Glycans/G82576YO | denotes | fucose |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T71 | 482-488 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T72 | 622-625 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T73 | 716-720 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T74 | 861-868 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T49 | 181-189 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T78 | 235-237 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T79 | 251-253 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T80 | 284-286 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
T81 | 375-377 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T82 | 375-377 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T83 | 716-720 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T84 | 899-901 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T133 | 45-52 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T134 | 86-95 | Chemical | denotes | immunogen | http://purl.obolibrary.org/obo/CHEBI_60816 |
T135 | 218-225 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T136 | 319-326 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T137 | 348-359 | Chemical | denotes | sialic acid | http://purl.obolibrary.org/obo/CHEBI_26667 |
T138 | 355-359 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T139 | 375-377 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T140 | 387-389 | Chemical | denotes | S3 | http://purl.obolibrary.org/obo/CHEBI_29388 |
T141 | 466-473 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T142 | 482-488 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
T143 | 499-505 | Chemical | denotes | Glycan | http://purl.obolibrary.org/obo/CHEBI_18154 |
T144 | 682-689 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T145 | 762-769 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T146 | 861-868 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T62 | 277-282 | http://purl.obolibrary.org/obo/BFO_0000029 | denotes | sites |
T63 | 716-720 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17701 | 0-12 | RB | denotes | Additionally |
T99697 | 12-13 | -COMMA- | denotes | , |
T80820 | 14-17 | DT | denotes | the |
T76134 | 18-28 | NN | denotes | processing |
T62423 | 29-31 | IN | denotes | of |
T20120 | 32-44 | JJ | denotes | complex-type |
T70317 | 45-52 | NNS | denotes | glycans |
T54945 | 53-55 | VBZ | denotes | is |
T38495 | 56-58 | DT | denotes | an |
T67133 | 59-68 | JJ | denotes | important |
T62820 | 69-82 | NN | denotes | consideration |
T6640 | 83-85 | IN | denotes | in |
T89341 | 86-95 | NN | denotes | immunogen |
T16198 | 96-107 | NN | denotes | engineering |
T34295 | 107-108 | -COMMA- | denotes | , |
T17998 | 109-119 | RB | denotes | especially |
T48208 | 120-131 | VBG | denotes | considering |
T59621 | 132-136 | IN | denotes | that |
T38335 | 137-145 | NNS | denotes | epitopes |
T17632 | 146-148 | IN | denotes | of |
T52650 | 149-161 | VBG | denotes | neutralizing |
T94803 | 162-172 | NNS | denotes | antibodies |
T96472 | 173-180 | IN | denotes | against |
T15388 | 181-191 | NN | denotes | SARS-CoV-2 |
T65870 | 192-193 | NN | denotes | S |
T54929 | 194-197 | MD | denotes | can |
T48495 | 198-205 | VB | denotes | contain |
T83428 | 206-217 | VBN | denotes | fucosylated |
T33605 | 218-225 | NNS | denotes | glycans |
T61395 | 226-228 | IN | denotes | at |
T85817 | 229-233 | NN | denotes | N343 |
T96270 | 234-235 | -LRB- | denotes | ( |
T72262 | 235-237 | CD | denotes | 35 |
T73516 | 237-238 | -RRB- | denotes | ) |
T58385 | 240-246 | IN | denotes | Across |
T33257 | 247-250 | DT | denotes | the |
T7279 | 251-253 | CD | denotes | 22 |
T66085 | 254-262 | JJ | denotes | N-linked |
T50825 | 263-276 | NN | denotes | glycosylation |
T5111 | 277-282 | NNS | denotes | sites |
T97279 | 282-283 | -COMMA- | denotes | , |
T26983 | 284-286 | CD | denotes | 52 |
T69394 | 286-287 | NN | denotes | % |
T83730 | 288-291 | VBP | denotes | are |
T54583 | 292-303 | VBN | denotes | fucosylated |
T26054 | 304-307 | CC | denotes | and |
T85194 | 308-310 | CD | denotes | 15 |
T20514 | 310-311 | NN | denotes | % |
T72708 | 312-314 | IN | denotes | of |
T31556 | 315-318 | DT | denotes | the |
T75023 | 319-326 | NNS | denotes | glycans |
T91101 | 327-334 | VBP | denotes | contain |
T15113 | 335-337 | IN | denotes | at |
T84490 | 338-343 | JJS | denotes | least |
T40607 | 344-347 | CD | denotes | one |
T99043 | 348-354 | JJ | denotes | sialic |
T62355 | 355-359 | NN | denotes | acid |
T95450 | 360-367 | NN | denotes | residue |
T41689 | 368-369 | -LRB- | denotes | ( |
T78019 | 369-374 | NN | denotes | table |
T59791 | 375-377 | NN | denotes | S2 |
T12029 | 378-381 | CC | denotes | and |
T36301 | 382-385 | NN | denotes | fig |
T18591 | 387-389 | NN | denotes | S3 |
T69202 | 389-390 | -RRB- | denotes | ) |
T88205 | 392-395 | PRP-DOLLAR- | denotes | Our |
T66239 | 396-404 | NN | denotes | analysis |
T85946 | 405-412 | VBZ | denotes | reveals |
T29321 | 413-417 | IN | denotes | that |
T6259 | 418-422 | NN | denotes | N343 |
T81525 | 423-425 | VBZ | denotes | is |
T30157 | 426-432 | RB | denotes | highly |
T97849 | 433-444 | VBN | denotes | fucosylated |
T21442 | 445-449 | IN | denotes | with |
T82188 | 450-452 | CD | denotes | 98 |
T6571 | 452-453 | NN | denotes | % |
T40587 | 454-456 | IN | denotes | of |
T88519 | 457-465 | VBN | denotes | detected |
T23189 | 466-473 | NNS | denotes | glycans |
T84265 | 474-481 | VBG | denotes | bearing |
T71335 | 482-488 | NN | denotes | fucose |
T50000 | 489-497 | NNS | denotes | residues |
T89016 | 499-505 | NN | denotes | Glycan |
T93436 | 506-519 | NNS | denotes | modifications |
T75195 | 520-523 | MD | denotes | can |
T94836 | 524-526 | VB | denotes | be |
T43397 | 527-534 | RB | denotes | heavily |
T35429 | 535-545 | VBN | denotes | influenced |
T42310 | 546-548 | IN | denotes | by |
T34958 | 549-552 | DT | denotes | the |
T16911 | 553-561 | JJ | denotes | cellular |
T68653 | 562-572 | NN | denotes | expression |
T23470 | 573-579 | NN | denotes | system |
T99582 | 580-584 | VBN | denotes | used |
T97181 | 586-588 | PRP | denotes | We |
T55441 | 589-593 | VBP | denotes | have |
T9573 | 594-604 | RB | denotes | previously |
T58273 | 605-617 | VBN | denotes | demonstrated |
T28968 | 618-621 | IN | denotes | for |
T34125 | 622-627 | NN | denotes | HIV-1 |
T85697 | 628-631 | NN | denotes | Env |
T43925 | 632-645 | NN | denotes | glycosylation |
T72928 | 646-650 | IN | denotes | that |
T20432 | 651-654 | DT | denotes | the |
T74575 | 655-665 | NN | denotes | processing |
T86628 | 666-668 | IN | denotes | of |
T60989 | 669-681 | JJ | denotes | complex-type |
T13027 | 682-689 | NNS | denotes | glycans |
T11801 | 690-692 | VBZ | denotes | is |
T93111 | 693-699 | VBN | denotes | driven |
T68502 | 700-702 | IN | denotes | by |
T25582 | 703-706 | DT | denotes | the |
T45914 | 707-715 | NN | denotes | producer |
T65172 | 716-720 | NN | denotes | cell |
T99350 | 721-724 | CC | denotes | but |
T88282 | 725-729 | IN | denotes | that |
T3049 | 730-733 | DT | denotes | the |
T57577 | 734-740 | NNS | denotes | levels |
T64683 | 741-743 | IN | denotes | of |
T18565 | 744-761 | JJ | denotes | oligomannose-type |
T45265 | 762-769 | NNS | denotes | glycans |
T16371 | 770-774 | VBD | denotes | were |
T17100 | 775-782 | RB | denotes | largely |
T68235 | 783-794 | JJ | denotes | independent |
T82363 | 795-797 | IN | denotes | of |
T15827 | 798-801 | DT | denotes | the |
T31780 | 802-812 | NN | denotes | expression |
T24822 | 813-819 | NN | denotes | system |
T93088 | 820-823 | CC | denotes | and |
T37436 | 824-827 | VBP | denotes | are |
T64666 | 828-832 | RB | denotes | much |
T48018 | 833-837 | RBR | denotes | more |
T54557 | 838-845 | RB | denotes | closely |
T92543 | 846-853 | JJ | denotes | related |
T5056 | 854-856 | TO | denotes | to |
T95680 | 857-860 | DT | denotes | the |
T83467 | 861-868 | NN | denotes | protein |
T6736 | 869-878 | NN | denotes | structure |
T70311 | 879-882 | CC | denotes | and |
T36895 | 883-889 | NN | denotes | glycan |
T93693 | 890-897 | NN | denotes | density |
T72545 | 898-899 | -LRB- | denotes | ( |
T3335 | 899-901 | CD | denotes | 36 |
T19113 | 901-902 | -RRB- | denotes | ) |
R55019 | T97849 | T29321 | arg1Of | fucosylated,that |
R46867 | T6259 | T81525 | arg1Of | N343,is |
R97275 | T97849 | T81525 | arg2Of | fucosylated,is |
R57502 | T97849 | T21442 | arg1Of | fucosylated,with |
R92411 | T6571 | T21442 | arg2Of | %,with |
R8445 | T6571 | T82188 | arg1Of | %,98 |
R93240 | T6571 | T40587 | arg1Of | %,of |
R73848 | T23189 | T40587 | arg2Of | glycans,of |
R47193 | T23189 | T88519 | arg2Of | glycans,detected |
R27311 | T23189 | T84265 | arg1Of | glycans,bearing |
R11429 | T50000 | T84265 | arg2Of | residues,bearing |
R29945 | T50000 | T71335 | arg1Of | residues,fucose |
R75763 | T93436 | T89016 | arg1Of | modifications,Glycan |
R25702 | T93436 | T75195 | arg1Of | modifications,can |
R95805 | T35429 | T75195 | arg2Of | influenced,can |
R64251 | T93436 | T94836 | arg1Of | modifications,be |
R26958 | T35429 | T94836 | arg2Of | influenced,be |
R64442 | T35429 | T43397 | arg1Of | influenced,heavily |
R63094 | T48018 | T64666 | arg1Of | more,much |
R5963 | T92543 | T48018 | arg1Of | related,more |
R17467 | T92543 | T54557 | arg1Of | related,closely |
R93728 | T57577 | T92543 | arg1Of | levels,related |
R75227 | T92543 | T5056 | arg1Of | related,to |
R97368 | T70311 | T5056 | arg2Of | and,to |
R28855 | T6736 | T95680 | arg1Of | structure,the |
R68944 | T6736 | T83467 | arg1Of | structure,protein |
R59661 | T6736 | T70311 | arg1Of | structure,and |
R27972 | T93693 | T70311 | arg2Of | density,and |
R58434 | T93693 | T36895 | arg1Of | density,glycan |
R9247 | T93693 | T72545 | arg1Of | density,( |
R76485 | T3335 | T72545 | arg2Of | 36,( |
R37324 | T19113 | T72545 | arg3Of | ),( |
R29415 | T54945 | T17701 | arg1Of | is,Additionally |
R61604 | T54945 | T99697 | arg1Of | is,"," |
R11134 | T76134 | T80820 | arg1Of | processing,the |
R58591 | T76134 | T62423 | arg1Of | processing,of |
R53097 | T70317 | T62423 | arg2Of | glycans,of |
R6410 | T70317 | T20120 | arg1Of | glycans,complex-type |
R31957 | T76134 | T54945 | arg1Of | processing,is |
R64311 | T62820 | T54945 | arg2Of | consideration,is |
R92980 | T62820 | T38495 | arg1Of | consideration,an |
R74257 | T62820 | T67133 | arg1Of | consideration,important |
R89401 | T54945 | T6640 | arg1Of | is,in |
R2801 | T16198 | T6640 | arg2Of | engineering,in |
R5066 | T16198 | T89341 | arg1Of | engineering,immunogen |
R63887 | T54945 | T34295 | arg1Of | is,"," |
R45258 | T48208 | T17998 | arg1Of | considering,especially |
R11776 | T76134 | T48208 | arg1Of | processing,considering |
R23707 | T48495 | T48208 | arg2Of | contain,considering |
R3350 | T54945 | T48208 | modOf | is,considering |
R64055 | T48495 | T59621 | arg1Of | contain,that |
R77893 | T38335 | T17632 | arg1Of | epitopes,of |
R80213 | T94803 | T17632 | arg2Of | antibodies,of |
R85241 | T94803 | T52650 | arg1Of | antibodies,neutralizing |
R48071 | T94803 | T96472 | arg1Of | antibodies,against |
R50900 | T65870 | T96472 | arg2Of | S,against |
R11381 | T65870 | T15388 | arg1Of | S,SARS-CoV-2 |
R24221 | T38335 | T54929 | arg1Of | epitopes,can |
R33143 | T48495 | T54929 | arg2Of | contain,can |
R40503 | T38335 | T48495 | arg1Of | epitopes,contain |
R13697 | T33605 | T48495 | arg2Of | glycans,contain |
R22889 | T33605 | T83428 | arg2Of | glycans,fucosylated |
R87734 | T48495 | T61395 | arg1Of | contain,at |
R83302 | T85817 | T61395 | arg2Of | N343,at |
R89433 | T85817 | T96270 | arg1Of | N343,( |
R12740 | T72262 | T96270 | arg2Of | 35,( |
R17492 | T73516 | T96270 | arg3Of | ),( |
R29512 | T26054 | T58385 | arg1Of | and,Across |
R16840 | T5111 | T58385 | arg2Of | sites,Across |
R72478 | T5111 | T33257 | arg1Of | sites,the |
R71033 | T5111 | T7279 | arg1Of | sites,22 |
R63820 | T5111 | T66085 | arg1Of | sites,N-linked |
R36388 | T5111 | T50825 | arg1Of | sites,glycosylation |
R30804 | T26054 | T97279 | arg1Of | and,"," |
R5539 | T69394 | T26983 | arg1Of | %,52 |
R45010 | T69394 | T83730 | arg1Of | %,are |
R44415 | T54583 | T83730 | arg2Of | fucosylated,are |
R14603 | T69394 | T54583 | arg2Of | %,fucosylated |
R44577 | T54583 | T26054 | arg1Of | fucosylated,and |
R89328 | T91101 | T26054 | arg2Of | contain,and |
R71419 | T20514 | T85194 | arg1Of | %,15 |
R84178 | T20514 | T72708 | arg1Of | %,of |
R52453 | T75023 | T72708 | arg2Of | glycans,of |
R31250 | T75023 | T31556 | arg1Of | glycans,the |
R70625 | T20514 | T91101 | arg1Of | %,contain |
R74763 | T12029 | T91101 | arg2Of | and,contain |
R25451 | T40607 | T15113 | arg1Of | one,at |
R58083 | T40607 | T84490 | arg1Of | one,least |
R63012 | T12029 | T40607 | arg1Of | and,one |
R90513 | T78019 | T99043 | arg1Of | table,sialic |
R88927 | T78019 | T62355 | arg1Of | table,acid |
R74487 | T78019 | T95450 | arg1Of | table,residue |
R72833 | T78019 | T41689 | arg1Of | table,( |
R86175 | T12029 | T78019 | arg1Of | and,table |
R98500 | T59791 | T12029 | arg1Of | S2,and |
R62995 | T36301 | T12029 | arg2Of | fig,and |
R20369 | T18591 | T69202 | arg1Of | S3,) |
R11225 | T66239 | T88205 | arg1Of | analysis,Our |
R92569 | T66239 | T85946 | arg1Of | analysis,reveals |
R47442 | T97849 | T85946 | arg2Of | fucosylated,reveals |
R12844 | T97849 | T30157 | arg1Of | fucosylated,highly |
R87026 | T6259 | T97849 | arg2Of | N343,fucosylated |
R62424 | T23470 | T35429 | arg1Of | system,influenced |
R30352 | T93436 | T35429 | arg2Of | modifications,influenced |
R3501 | T23470 | T42310 | arg2Of | system,by |
R15802 | T23470 | T34958 | arg1Of | system,the |
R37538 | T23470 | T16911 | arg1Of | system,cellular |
R14634 | T23470 | T68653 | arg1Of | system,expression |
R27963 | T23470 | T99582 | arg2Of | system,used |
R14220 | T97181 | T55441 | arg1Of | We,have |
R97683 | T58273 | T55441 | arg2Of | demonstrated,have |
R24011 | T58273 | T9573 | arg1Of | demonstrated,previously |
R78803 | T97181 | T58273 | arg1Of | We,demonstrated |
R20525 | T99350 | T58273 | arg2Of | but,demonstrated |
R78593 | T58273 | T28968 | arg1Of | demonstrated,for |
R99891 | T43925 | T28968 | arg2Of | glycosylation,for |
R13650 | T43925 | T34125 | arg1Of | glycosylation,HIV-1 |
R31307 | T43925 | T85697 | arg1Of | glycosylation,Env |
R78477 | T93111 | T72928 | arg1Of | driven,that |
R26231 | T74575 | T20432 | arg1Of | processing,the |
R77353 | T74575 | T86628 | arg1Of | processing,of |
R99911 | T13027 | T86628 | arg2Of | glycans,of |
R5099 | T13027 | T60989 | arg1Of | glycans,complex-type |
R9381 | T74575 | T11801 | arg1Of | processing,is |
R32118 | T93111 | T11801 | arg2Of | driven,is |
R77992 | T65172 | T93111 | arg1Of | cell,driven |
R20715 | T74575 | T93111 | arg2Of | processing,driven |
R46329 | T65172 | T68502 | arg2Of | cell,by |
R70216 | T65172 | T25582 | arg1Of | cell,the |
R65543 | T65172 | T45914 | arg1Of | cell,producer |
R92721 | T93111 | T99350 | arg1Of | driven,but |
R84237 | T88282 | T99350 | arg2Of | that,but |
R90416 | T93088 | T88282 | arg2Of | and,that |
R5226 | T57577 | T3049 | arg1Of | levels,the |
R15770 | T57577 | T64683 | arg1Of | levels,of |
R94955 | T45265 | T64683 | arg2Of | glycans,of |
R39858 | T45265 | T18565 | arg1Of | glycans,oligomannose-type |
R43574 | T57577 | T16371 | arg1Of | levels,were |
R40932 | T68235 | T16371 | arg2Of | independent,were |
R83339 | T68235 | T17100 | arg1Of | independent,largely |
R73052 | T57577 | T68235 | arg1Of | levels,independent |
R41635 | T68235 | T82363 | arg1Of | independent,of |
R79932 | T24822 | T82363 | arg2Of | system,of |
R44668 | T24822 | T15827 | arg1Of | system,the |
R66533 | T24822 | T31780 | arg1Of | system,expression |
R74469 | T16371 | T93088 | arg1Of | were,and |
R22343 | T37436 | T93088 | arg2Of | are,and |
R96733 | T57577 | T37436 | arg1Of | levels,are |
R76661 | T92543 | T37436 | arg2Of | related,are |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T73 | 861-868 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T70 | 482-488 | Body_part | denotes | fucose | http://purl.org/sig/ont/fma/fma82790 |
T71 | 622-625 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T72 | 716-720 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T102 | 45-52 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T103 | 218-225 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T104 | 319-326 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T105 | 348-359 | Chemical | denotes | sialic acid | http://purl.obolibrary.org/obo/CHEBI_26667 |
T106 | 466-473 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T107 | 482-488 | Chemical | denotes | fucose | http://purl.obolibrary.org/obo/CHEBI_33984 |
T108 | 499-505 | Chemical | denotes | Glycan | http://purl.obolibrary.org/obo/CHEBI_18154 |
T109 | 682-689 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T110 | 762-769 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T111 | 861-868 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T53 | 181-191 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
T54 | 622-627 | Species | denotes | HIV-1 | NCBItxid:11676 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T88 | 0-239 | Sentence | denotes | Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). |
T89 | 240-391 | Sentence | denotes | Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3). |
T90 | 392-498 | Sentence | denotes | Our analysis reveals that N343 is highly fucosylated with 98% of detected glycans bearing fucose residues. |
T91 | 499-585 | Sentence | denotes | Glycan modifications can be heavily influenced by the cellular expression system used. |
T92 | 586-903 | Sentence | denotes | We have previously demonstrated for HIV-1 Env glycosylation that the processing of complex-type glycans is driven by the producer cell but that the levels of oligomannose-type glycans were largely independent of the expression system and are much more closely related to the protein structure and glycan density (36). |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T43 | 181-191 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
454 | 192-193 | Gene | denotes | S | Gene:43740568 |
455 | 181-191 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
456 | 45-52 | Chemical | denotes | glycans | MESH:D011134 |
457 | 218-225 | Chemical | denotes | glycans | MESH:D011134 |
458 | 254-255 | Chemical | denotes | N | MESH:D009584 |
459 | 319-326 | Chemical | denotes | glycans | MESH:D011134 |
460 | 348-359 | Chemical | denotes | sialic acid | MESH:D019158 |
461 | 418-422 | Chemical | denotes | N343 | |
462 | 466-473 | Chemical | denotes | glycans | MESH:D011134 |
463 | 482-488 | Chemical | denotes | fucose | MESH:D005643 |
464 | 499-505 | Chemical | denotes | Glycan | MESH:D011134 |
465 | 682-689 | Chemical | denotes | glycans | MESH:D011134 |
466 | 744-756 | Chemical | denotes | oligomannose | |
467 | 762-769 | Chemical | denotes | glycans | MESH:D011134 |
468 | 883-889 | Chemical | denotes | glycan | MESH:D011134 |
469 | 622-645 | Disease | denotes | HIV-1 Env glycosylation | MESH:D015658 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T2323 | 628-631 | Protein | denotes | Env | https://www.uniprot.org/uniprot/C1JJY3 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 263-276 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T36 | 632-645 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 263-276 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T34 | 632-645 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T38 | 254-276 | http://purl.obolibrary.org/obo/GO_0006487 | denotes | N-linked glycosylation |
T39 | 263-276 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T40 | 632-645 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T88 | 0-239 | Sentence | denotes | Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). |
T89 | 240-391 | Sentence | denotes | Across the 22 N-linked glycosylation sites, 52% are fucosylated and 15% of the glycans contain at least one sialic acid residue (table S2 and fig. S3). |
T90 | 392-498 | Sentence | denotes | Our analysis reveals that N343 is highly fucosylated with 98% of detected glycans bearing fucose residues. |
T91 | 499-585 | Sentence | denotes | Glycan modifications can be heavily influenced by the cellular expression system used. |
T92 | 586-903 | Sentence | denotes | We have previously demonstrated for HIV-1 Env glycosylation that the processing of complex-type glycans is driven by the producer cell but that the levels of oligomannose-type glycans were largely independent of the expression system and are much more closely related to the protein structure and glycan density (36). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
454 | 192-193 | Gene | denotes | S | Gene:43740568 |
455 | 181-191 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
456 | 45-52 | Chemical | denotes | glycans | MESH:D011134 |
457 | 218-225 | Chemical | denotes | glycans | MESH:D011134 |
458 | 254-255 | Chemical | denotes | N | MESH:D009584 |
459 | 319-326 | Chemical | denotes | glycans | MESH:D011134 |
460 | 348-359 | Chemical | denotes | sialic acid | MESH:D019158 |
461 | 418-422 | Chemical | denotes | N343 | |
462 | 466-473 | Chemical | denotes | glycans | MESH:D011134 |
463 | 482-488 | Chemical | denotes | fucose | MESH:D005643 |
464 | 499-505 | Chemical | denotes | Glycan | MESH:D011134 |
465 | 682-689 | Chemical | denotes | glycans | MESH:D011134 |
466 | 744-756 | Chemical | denotes | oligomannose | |
467 | 762-769 | Chemical | denotes | glycans | MESH:D011134 |
468 | 883-889 | Chemical | denotes | glycan | MESH:D011134 |
469 | 622-645 | Disease | denotes | HIV-1 Env glycosylation | MESH:D015658 |